选择性脂肪酶抑制性多杂环衍生物的发现与表征:一项计算机模拟与体外实验相结合的研究

Discovery and characterization of selective lipase-inhibiting polyheterocyclic derivatives: a combined in silico and in vitro study.

作者信息

Benguechoua Madjda, Benguechoua Mebarka Imene, Benarous Khedidja, Boulebd Houssem, Kadi Ibtissem, Mermer Arif, Şirin Yakup, Kaouka Alaeddine, Yousfi Mohamed

机构信息

Fundamental Sciences Laboratory, Faculty of Sciences, Amar Telidji University, Laghouat, Algeria.

Applied Sciences and Didactics Laboratory, Higher Normal School, Laghouat, Algeria.

出版信息

Turk J Biol. 2025 Jan 6;49(3):324-335. doi: 10.55730/1300-0152.2748. eCollection 2025.

Abstract

BACKGROUND/AIM: Obesity has become a global health crisis with an increasing prevalence, necessitating the search for effective therapies. Schiff base derivatives, known for their broad pharmacological activities, have gained attention as potential antiobesity agents. This study aimed to investigate the lipase inhibitory potential of novel Schiff base derivatives and assess their drug-like properties through in vitro assays and in silico methods.

MATERIALS AND METHODS

The lipase inhibitory activity of synthesized Schiff base derivatives was evaluated using in vitro assays, with IC values determined for each compound. Additionally, in silico ADMET predictions (absorption, distribution, metabolism, excretion, and toxicity), molecular docking studies, and density functional theory (DFT) calculations were conducted to assess the pharmacokinetic properties and binding potential of the compounds to the lipase active site.

RESULTS

The synthesized Schiff base derivatives demonstrated significant lipase inhibitory activity, with IC values of 995.74 ± 0.010 μM () and 1985.51 ± 0.041 μM (), comparable to the reference compound quercetin (843.06 ± 0.0007 μM). In silico ADMET analyses revealed that compounds and possess favorable pharmacokinetic properties and exhibit drug-like characteristics. Molecular docking studies showed robust binding interactions between these compounds and the lipase active site, which were further corroborated by DFT calculations that identified reactive regions and stable conformations. Among the compounds, compound exhibited the most effective inhibition and interaction profile, indicating its potential as a lipase inhibitor. These findings underscore the potential of Schiff base derivatives as promising antiobesity agents.

CONCLUSION

The results of our study highlight the potential of Schiff base derivatives as promising candidates for antiobesity therapy, given their significant lipase inhibitory activity and favorable in silico predictions. Further research is needed to elucidate the precise mechanisms of action and assess the efficacy of these compounds in vivo.

摘要

背景/目的:肥胖已成为一种全球健康危机,其患病率不断上升,因此需要寻找有效的治疗方法。席夫碱衍生物以其广泛的药理活性而闻名,作为潜在的抗肥胖药物受到了关注。本研究旨在通过体外试验和计算机模拟方法研究新型席夫碱衍生物的脂肪酶抑制潜力,并评估其类药性质。

材料与方法

使用体外试验评估合成的席夫碱衍生物的脂肪酶抑制活性,测定每种化合物的IC值。此外,进行了计算机模拟ADMET预测(吸收、分布、代谢、排泄和毒性)、分子对接研究和密度泛函理论(DFT)计算,以评估化合物的药代动力学性质及其与脂肪酶活性位点的结合潜力。

结果

合成的席夫碱衍生物表现出显著的脂肪酶抑制活性,IC值分别为995.74±0.010μM()和1985.51±0.041μM(),与参考化合物槲皮素(843.06±0.0007μM)相当。计算机模拟ADMET分析表明化合物和具有良好的药代动力学性质,并表现出类药特征。分子对接研究显示这些化合物与脂肪酶活性位点之间存在强烈的结合相互作用,DFT计算进一步证实了这一点,该计算确定了反应区域和稳定构象。在这些化合物中,化合物表现出最有效的抑制和相互作用特征,表明其作为脂肪酶抑制剂的潜力。这些发现强调了席夫碱衍生物作为有前景的抗肥胖药物的潜力。

结论

我们的研究结果突出了席夫碱衍生物作为抗肥胖治疗有前景候选药物的潜力,因为它们具有显著的脂肪酶抑制活性和良好的计算机模拟预测结果。需要进一步研究以阐明其确切作用机制并评估这些化合物在体内的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7d0/12266345/913bcdd45083/tjb-49-03-324f1.jpg

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索